CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,282 | -15.9% | 25,114 | 0.0% | 0.19% | -4.9% |
| Q2 2023 | $270,227 | +105046.7% | 25,114 | 0.0% | 0.20% | +1.0% |
| Q1 2023 | $257 | -3.0% | 25,114 | 0.0% | 0.20% | +7.5% |
| Q4 2022 | $265 | -99.9% | 25,114 | 0.0% | 0.19% | -17.6% |
| Q3 2022 | $322,000 | -44.3% | 25,114 | -44.3% | 0.23% | -46.0% |
| Q2 2022 | $578,000 | +22.5% | 45,114 | 0.0% | 0.42% | +23.5% |
| Q1 2022 | $472,000 | -32.2% | 45,114 | 0.0% | 0.34% | -24.3% |
| Q4 2021 | $696,000 | -31.6% | 45,114 | 0.0% | 0.45% | -35.2% |
| Q3 2021 | $1,018,000 | -12.4% | 45,114 | 0.0% | 0.69% | -0.3% |
| Q2 2021 | $1,162,000 | -53.6% | 45,114 | -25.0% | 0.70% | -53.3% |
| Q1 2021 | $2,505,000 | – | 60,114 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |